Concepedia
Statistics
Publications
41
Citations
2.8K
H-Index
28
Active since
1999
Affiliations
University of Toronto(Current)
Structural Genomics Consortium
Princess Margaret Cancer Centre
Ontario Institute for Cancer Research
Icahn School of Medicine at Mount Sinai
David Smil is an author at University of Toronto specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1999–2021
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
Florian Grebien, Masoud Vedadi, Matthäus Getlik et al. · Nature Chemical Biology · 2015 · 292 citations · Full text
Medicine, Cancer Biology, Pharmacology +5
Potassium Alkenyl- and Aryltrifluoroborates: Stable and Efficient Agents for Rhodium-Catalyzed Addition to Aldehydes and Enones
Robert A. Batey, Avinash N. Thadani, David Smil · Organic Letters · 1999 · 189 citations
Natural Sciences, Chemistry, Catalysis +8
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
Guillermo Senisterra, Hong Wu, Abdellah Allali‐Hassani et al. · Biochemical Journal · 2012 · 162 citations · Full text
Life Sciences, Cancer Biology, Molecular Biology +15
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
Sebastian Scheer, Suzanne Ackloo, Tiago da Silva Medina et al. · Nature Communications · 2018 · 149 citations · Full text
Life Sciences, Chemical Biology, Molecular Biology +13
A Potent, Selective and Cell‐Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3)
H. Ümit Kanıskan, Magdalena M. Szewczyk, Zhengtian Yu et al. · Angewandte Chemie International Edition · 2015 · 127 citations · Full text
Life Sciences, Biochemistry, Pharmacology +17
1–5 of 41